These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 540075)

  • 1. [Neurophysiological study of 36 patients with cerebral vascular processes treated with nicergoline (author's transl)].
    Samsó Dies JM; Villa Badó J; Villalobos J; Iriarte JL; Ordeix R
    Arzneimittelforschung; 1979; 29(8a):1301-7. PubMed ID: 540075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The role of nicergoline in the symptomatic treatment of arterial hypertension and chronic cerebrovascular insufficiency. A study on 359 observations (author's transl)].
    Dauverchain J
    Arzneimittelforschung; 1979; 29(8a):1308-10. PubMed ID: 395956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Psychopathometric double blind study with nicergoline versus placebo in geriatric patients with slight transit syndromes].
    Blaha L; Burkard G; Lehrl S; Kapinas K
    Arzneimittelforschung; 1979; 29(8a):1295-301. PubMed ID: 395955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Electroencephalography and psychometric measurements during the treatment of cerebral insufficiency with nicergoline and dihydroergotamine mesylate].
    Kugler JE; Meurer-Krüll BC
    Arzneimittelforschung; 1985; 35(12):1865-70. PubMed ID: 3913425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Quantitative EEG examinations on the vigilance stabilizing effect of nicergoline / Results of a double blind study with gerontopsychiatric patients (author's transl)].
    Bente D; Glatthaar G; Ulrich G; Lewinsky M
    Arzneimittelforschung; 1979; 29(11):1804-8. PubMed ID: 543890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Interaction between anti-aggregating and anticoagulant agents. A double blind study on the concomitant administration of nicergoline and acenocoumarols].
    Pogliani E; Recalcati P; Tantalo V; Bregnani P
    Arzneimittelforschung; 1979; 29(8a):1266-9. PubMed ID: 395954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effects of nicergoline on cerebral blood flow (author's transl)].
    Iliff LD; Du Boulay GH; Marshall J; Ross Russell RW; Symon L
    Arzneimittelforschung; 1979; 29(8a):1277-8. PubMed ID: 540071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Nicergoline and platelet aggregation. A review of experimental and clinical studies (author's transl)].
    Praga C; Tantalo V; Marangoni R
    Arzneimittelforschung; 1979; 29(8a):1270-6. PubMed ID: 540070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Influence of nicergoline on the cerebral blood flow and alpha-sympatholytical properties (author's transl)].
    Lievre M; Ollagnier M; Faucon G
    Arzneimittelforschung; 1979; 29(8a):1227-31. PubMed ID: 44198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Therapeutic efficacy of nicergoline in ophthalmology. Fluorescence retinographic study (author's transl)].
    Borgioli M; Merendino E; Ricci B
    Arzneimittelforschung; 1979; 29(8a):1311-6. PubMed ID: 540076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Therapy of multi-infarct dementia with nicergoline: double-blind, clinical, psychometric and EEG imaging studies with 2 dosage schedules].
    Saletu B; Hochmayer I; Grünberger J; Böhmer F; Paroubek J; Wicke L; Neuhold A
    Wien Med Wochenschr; 1987 Nov; 137(22):513-24. PubMed ID: 3324497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Initial dyscirculatory encephalopathy in middle-aged and elderly patients (problems of early diagnosis and therapy)].
    Man'kovskiĭ NB; Mints AIa; Karaban' IN
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1989; 89(1):16-20. PubMed ID: 2718657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Physiopathology of the inner ear and therapy of presbyacusis (author's transl)].
    Aliprandi G; Tantalo V
    Arzneimittelforschung; 1979; 29(8a):1287-95. PubMed ID: 540074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinico-rheographic study of the cerebrovascular effect of alpha-adrenergic blockers in vascular diseases of the brain].
    Shtok VN; Varlamova IV; Fedorova NV; Timurbaator
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1985; 85(9):1333-8. PubMed ID: 4072531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Metabolic and neurochemical effects of nicergoline on the central nervous system. A review of the experimental studies (author's transl)].
    Moretti A
    Arzneimittelforschung; 1979; 29(8a):1213-23. PubMed ID: 395953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effectiveness of nicergoline in the treatment of chronic cerebrovascular insufficiency (author's transl)].
    Kaemmerer E
    Nervenarzt; 1980 Jun; 51(6):368-72. PubMed ID: 7453888
    [No Abstract]   [Full Text] [Related]  

  • 17. [Ultrastructural study on the effect of an inhibitor of platelet aggregation (author's transl)].
    Le Menn R; Migne J; Probst-Dvojakovic RJ
    Arzneimittelforschung; 1979; 29(8a):1278-82. PubMed ID: 540072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Buflomedil and nicergoline in the targeted treatment of acute cerebral ischemia. Randomized comparative double blind study].
    Bossi L
    Minerva Med; 1985 May; 76(21):1005-18. PubMed ID: 3889723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Haemodynamic and metabolic effects of exercise test in diabetic patients with arteritis treated or not with nicergoline (author's transl)].
    Boismare F; Leclerc JL; Lefrançois J; Moore N; Paux G; Schrub JC; Vuillermet P
    Sem Hop; 1981 Sep 18-25; 57(33-36):1455-7. PubMed ID: 6270809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Therapy of demonstrated cerebral ischemia with nicergoline (Sermion)].
    Karyofilis A
    Ther Ggw; 1980 Dec; 119(12):1478-85. PubMed ID: 7466692
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.